The anti-tumor protective effect in vivo by Rb9 involved mainly dendritic cells, T cell effector lymphocytes, cytokines, and several regulatory mechanisms of which the MIF-CD74 interaction appears to be most relevant. Here, CD74 is linked to neoplasm.